Cargando…

Variant constraint by mRNA vaccines

The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.

Detalles Bibliográficos
Autor principal:	Bordon, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034506/ https://www.ncbi.nlm.nih.gov/pubmed/33837367 http://dx.doi.org/10.1038/s41577-021-00548-5

Ejemplares similares

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Coronavirus Variants—Will New mRNA Vaccines Meet the Challenge?
por: Welsh, Jennifer
Publicado: (2021)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Immune readouts from the Oxford COVID-19 vaccine
por: Bordon, Yvonne
Publicado: (2021)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021)

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

Puzzling mRNA: Alternative splicing fine-tunes specificity and function
por: Häfner, Sophia Julia
Publicado: (2019)

A deadly fibroblast response to flu
por: Bordon, Yvonne
Publicado: (2020)

Disturbance of cytoskeleton primes RIG-I-like receptors
por: Bordon, Yvonne
Publicado: (2022)

Immune dysregulation in Down syndrome
por: Bordon, Yvonne
Publicado: (2023)

Highlight: Not Like a Textbook—Nuclear Genes in Blastocystis Use mRNA Polyadenylation for Stop Codons
por: Venton, Danielle
Publicado: (2014)

The greatest catch: big game fishing for mRNA-bound proteins
por: Sibley, Christopher R, et al.
Publicado: (2012)

The 3′ end of the story: deciphering combinatorial interactions that control mRNA fate
por: Sanford, Jeremy R., et al.
Publicado: (2017)

Lipid nanoparticle-mRNA: another step in the fight against COVID-19
por: Verma, Abhishek Kumar, et al.
Publicado: (2022)

Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia
por: Klapp, Vanessa, et al.
Publicado: (2023)

How to package and SEND mRNA: a novel “humanized” vector system based on endogenous retroviruses
por: Riecken, Kristoffer, et al.
Publicado: (2021)

Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing
por: Meng, Ning, et al.
Publicado: (2021)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

Mutated trimeric RBD vaccines: a platform against variants of concern
por: Aparicio, Belén, et al.
Publicado: (2023)

Granulation of m(1)A-modified mRNAs protects their functionality through cellular stress
por: Jiang, Hao
Publicado: (2020)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

Explorative probes and biomarkers, chronic Salmonella infections and future vaccines
por: Michán, Carmen, et al.
Publicado: (2012)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Substrates of the m(6)A demethylase FTO: FTO-LINE1 RNA axis regulates chromatin state in mESCs
por: Sommerkamp, Pia
Publicado: (2022)

Fate by RNA methylation: m(6)A steers stem cell pluripotency
por: Zhao, Boxuan Simen, et al.
Publicado: (2015)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

Social distancing plus rapid vaccination prevents emergence of SARS-CoV-2 variants
por: Bordon, Yvonne
Publicado: (2022)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Plant Pollen Grains: A Move Towards Green Drug and Vaccine Delivery Systems
por: Iravani, Siavash, et al.
Publicado: (2021)

Highlight: Birds Take tRNA Efficiency to New Heights
por: McGrath, Casey
Publicado: (2021)

New insights into pathogen-mediated modulation of host RNA splicing
por: Gao, Chuyun, et al.
Publicado: (2022)

A comprehensive model for tRNA methylation modification studies
por: Weng, Qi, et al.
Publicado: (2023)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

RNA methylation into m(1)A era: a new regulation over T-cell function
por: Lin, Ping, et al.
Publicado: (2023)

Intricacies in the cross talk between metabolic enzymes, RNA, and protein translation
por: Lv, Yuan, et al.
Publicado: (2019)

New discoveries on how DICER efficiently processes pre‐miRNA
por: Weng, Qi, et al.
Publicado: (2023)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2fc97i6vhkgpgiv7shfqfp4d3c